Sinopharm Group Co., Ltd.

Sinopharm Group Co., Ltd., also known as China National Pharmaceutical Group Corporation, is one of the largest and most prominent state-owned pharmaceutical companies in China. It was established in 1998 and is headquartered in Beijing, China. Sinopharm is involved in various aspects of the pharmaceutical industry, including research, development, manufacturing, distribution, and retail.

The company's business spans a wide range of pharmaceutical products, including prescription drugs, over-the-counter medications, vaccines, traditional Chinese medicines, and medical devices. Sinopharm has a robust presence in the Chinese healthcare market and plays a crucial role in supplying essential medications and vaccines to meet the country's healthcare needs.

Sinopharm has also made significant contributions to global health, especially during the COVID-19 pandemic. The company has been actively involved in the production and distribution of COVID-19 vaccines, including inactivated virus vaccines. Their efforts have played a critical role in vaccination campaigns both within China and in other countries.

In addition to its pharmaceutical business, Sinopharm operates a chain of retail pharmacies, offering pharmaceutical and healthcare products directly to consumers. This retail segment further strengthens the company's position in the healthcare industry.

As a state-owned enterprise, Sinopharm Group operates under the guidance and policies of the Chinese government, and its activities align with national healthcare priorities and initiatives.

Founded: 2003

Headquarters: Sinopharm Plaza, Shanghai, China

Website: http://ir.sinopharmgroup.com.cn/html/index.php